To assess the conditions that precede DCIS_noamp to becoming HER2-amplified, we collected 30 DCIS ducts (DCIS_neg) from 10 HER2-negative breast cancer patients (Supplementary Table 5). Here, ERBB2 is linked to breast carcinoma.